Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.

Saved in:
Bibliographic Details
Title: Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Authors: Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jyssum I; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Alirezaylavasani A; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Egner IM; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., The Tran T; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Tietze L; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Lund KP; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Ørbo H; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jørgensen K; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Source: Frontiers in immunology [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1296273. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1296273